Cell line · CVCL_Y019
Papers87
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
1 to 20 of 87
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Targeting tankyrase scaffolding in the β-catenin destruction complex by PROTAC overcomes the limitation of catalytic inhibitors in colorectal cancer. | Elife | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A validated antibody toolbox for ALS research. | Elife | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A lipid transfer-dependent feedback loop activates ATG9A compartments in autophagy initiation. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A guide to selecting high-performing antibodies for ARID1B (UniProt ID: Q8NFD5) for use in western blot and immunoprecipitation. | F1000Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A guide to selecting high-performing antibodies for Syntenin-1 (O00560) for use in western blot, immunoprecipitation, and immunofluorescence. | F1000Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MYDGF as a telomerase activator and therapeutic target for osteoarthritis. | Adv Biotechnol (Singap) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Posaconazole mitigates α-amanitin-induced liver injury by inhibiting STT3B-mediated glycosylation and cellular uptake. | Front Pharmacol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The regulation of protein phosphatase 4 by FBXO42 is required for cancer cell survival. | EMBO Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Leukemia risk factor ARID5B coordinates HDAC-mediated transcriptional repression. | Nucleic Acids Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PARG Governs a PARylation-Ubiquitination Toggle that Stabilizes RAD51AP1 to Drive Homologous Recombination-Mediated Chemoresistance. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A guide to selecting high-performing antibodies for ARID2 (UniProt ID: Q68CP9) for use in western blot, immunoprecipitation, and immunofluorescence. | F1000Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeted KRASG12V Degradation In Vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Global genetic interaction network of a human cell maps conserved principles and informs functional interpretation of gene co-essentiality profiles. | Cell | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Interplay of SLC33A1-dependent and -independent Golgi sialic acid O-acetylation in CASD1 catalysis. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Covalent modification of a glutamic acid inspired by HaloTag technology. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cell density-dependent nuclear-cytoplasmic shuttling of SETDB1 integrates with Hippo signaling to regulate YAP1-mediated transcription. | FEBS Lett | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Quantitative analysis of genetic interactions in human cells from genome-wide CRISPR-Cas9 screens. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting a Glutamic Acid in PDEδ with Fluoromethyl-Aryl Electrophiles Impairs K-Ras Signaling. | J Med Chem | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Click-code-seq reveals strand biases of DNA oxidation and depurination in human genome. | Nat Chem Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A guide to selecting high-performing antibodies for GCase (UniProt ID: P04062) for use in western blot, immunoprecipitation, and immunofluorescence. | F1000Res | 2025 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_Y019/papers